NCT05263193View on ClinicalTrials.gov

Retrospective Study on Caplacizumab-treated Pediatric Patients With Immune-mediated Thrombocytopenic Purpura (iTTP)

CompletedOBSERVATIONAL
Enrollment

4

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

October 28, 2022

Study Completion Date

October 28, 2022

Conditions
Immune-mediated Thrombocytopenic Purpura
Interventions
DRUG

Caplacizumab

as in real world practice

Trial Locations (1)

91380

Sanofi-Aventis, Chilly-Mazarin

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY